A volta dos anorexígenos anfetamínicos: um retrocesso na prática da medicina baseada em evidências no Brasil;
La vuelta de los anorexígenos de tipo anfetamínico: un paso atrás en la práctica de la medicina basada en la evidencia en Brasil

dc.creatorPaumgartten, Francisco José Roma
dc.date2017-12-11T13:38:13Z
dc.date2017-12-11T13:38:13Z
dc.date2017
dc.date.accessioned2023-09-26T23:14:08Z
dc.date.available2023-09-26T23:14:08Z
dc.identifierPAUMGARTTEN, Francisco José Roma. The return of amphetamine-like anorectics: a backward step in the practice of evidence-based medicine in Brazil. Cadernos de Saúde Pública, v.33, n.10, p.1-3, 2017
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/23600
dc.identifier10.1590/0102-311x00124817
dc.identifier1678-4464
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8888336
dc.descriptionThat clinical practice should always stand on the best available scientific evidence may seem obvious. Practitioners, however, often use their own clinical judgement or reasoning rather than the best available evidence to choose the therapy prescribed to their patients. Clinical judgement, the cognitive process by which physicians analyze data, derive diagnosis, decide on therapies, and evaluate the outcomes, is influenced by individual beliefs, prior experience, and education and values and, therefore, is amenable to error and biases that may lead to equivocal decisions regarding the most effective and safest treatment for the patient. In his landmark book Clinical Judgement (1967), Alvan Feinstein 1 critically appraised this process of thinking by which physicians reach a decision in clinical practice. Archibald Cochrane 2 in Effectiveness and Efficiency: Random Reflections on Health Services (1972) also described that many clinical practices and therapeutic interventions that physicians believed to be effective were in fact unsupported by randomized controlled trials (RCTs). Subsequent contributions by Sackett et al. 3 laid down the foundations of an evidence-based approach to guide decision-making in clinical practice, known as Evidence-Based Medicine (EBM), a term coined by Eddy in 1987. EBM was defined by Sackett et al. 3 (p. 71) as “(…) the conscientious, explicit and judicious use of current best evidence in making decisions about care of individual patients”, i.e., “(…) integrating the individual clinical expertise with the best available external clinical evidence from systematic research”.
dc.formatapplication/pdf
dc.languageeng
dc.publisherENSP/Fiocruz
dc.rightsopen access
dc.subjectDepressores do Apetite
dc.subjectMedicina Baseada em Evidências
dc.subjectAppetite Depressants
dc.subjectEvidence-Based Medicine
dc.subjectDepressores do Apetite
dc.subjectMedicina Baseada em Evidências
dc.titleThe return of amphetamine-like anorectics: a backward step in the practice of evidence-based medicine in Brazil
dc.titleA volta dos anorexígenos anfetamínicos: um retrocesso na prática da medicina baseada em evidências no Brasil
dc.titleLa vuelta de los anorexígenos de tipo anfetamínico: un paso atrás en la práctica de la medicina basada en la evidencia en Brasil
dc.typeArticle


Este ítem pertenece a la siguiente institución